Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 2002

View Archived Issues

Takeda describes new promoters of sAPP secretion and their use in AD and other disorders

Antitumor compounds discovered at Zenyaku Kogyo

Novel antidiabetic compounds in early development at Sumitomo

Mitsubishi Pharma's new chemokine receptor antagonists

Development of long-acting second-generation IL-11 supported by SBIR grant

Two Eisai patents describe novel PAR1 antagonists for restenosis and other uses

Scientists at Servier present new antidiabetic DPP-IV inhibitors

Age-related anticonvulsant effects of MPEP assessed in rats

Results from Oxycyte animal studies

AIDSVAX B/E and AIDSVAX B/B receive fast track designation

Oral formulation of Triapine demonstrates oral bioavailability

OGX-011 enters clinical testing

Two pivotal phase III trials of Alprox-TD completed

Approval granted by FDA for GlaxoSmithKline's Pediarix combination vaccine

Medivir and Paradigm Therapeutics collaborate on protease inhibitor discovery

Extended-release Cipro cleared for uncomplicated urinary tract infections

Third major filing for long-acting insulin analogue

Acute migraine therapy from Pozen filed with the FDA

VRBPAC recommends the FDA approve intranasal influenza vaccine

Cell-permeable MOE RNA oligonucleotide with telomerase-inhibitory effects

Potent and selective factor Xa inhibitor discovered at Mochida

Targeting the uPA system with antibodies as a new approach to cancer therapy

Trifunctional bispecific antibody shows potential for B-cell lymphoma

Chlorthalidone superior to amlodipine or lisinopril in hypertension-related CVD

GW-572016 effective in model of tamoxifen-resistant breast cancer

Antitumor effects of CI-1033 in human breast cancer cells

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...